Patrick Campbell

An analysis of a Swedish obesity study with more than 20 years of follow-up data is detailing differences in life expectancy among patients who undergo bariatric surgery versus those opting for usual care.

An analysis of data from more than 9 million women details the increased odds of developing gestational diabetes, gestational hypertension, and other complications associated with having polycystic ovary syndrome.

Results from FIDELIO-DKD suggest finerenone was associated with reductions in progression of chronic kidney disease and potential improvements in cardiovascular health.

An analysis of more than 1 million singleton births in Denmark is detailing a potential association between maternal diabetes and increased risk of developing an eating disorder early in life.

Practical Cardiology advisory board member Tsuyoshi Kaneko, MD, reflects on 3 studies examining topics related to TAVR from late-breaking sessions at TCT Connect 2020.

Results of the SCOPE II trial from TCT Connect offer insight into the head-to-head comparison of ACURATE neo valve versus the CoreValve Evolut R System.

Raymond Douglas, MD, PhD, discusses trends in treatment of thyroid eye disease and how the approval of teprotumumab has impacted the prospect of treating the condition.

Results of REDUCE-IT PCI detail a 34% reduction in 5-point MACE and a 39% reduction in total events among patients receiving icosapent ethyl (Vascepa) in the original trial with a history of PCI.

An analysis of data from a California health survey suggests non-obese Vietnamese Americans were 60% more likely to have diabetes as their non-obese non-Hispanic White counterparts.

A Brigham and Women's-led study details trends in incidence, characteristics, and outcomes of surgical explantation following TAVR among patients in the US.

An analysis of a Swedish obesity study with more than 20 years of follow-up data is detailing differences in life expectancy among patients who undergo bariatric surgery versus those opting for usual care.

Results from 3-year follow-up of the ULTIMATE study indicate IVUS-guided PCI was associated with lower rates of TVF and stent thrombosis.

The LIVMOR Halo AF Detection System has received 510(k) clearance from the US FDA and becomes the first prescriptible wearable for continuous heart monitoring in patients with atrial fibrillation.

The LIVMOR Halo AF Detection System has received 510(k) clearance from the US FDA and becomes the first prescriptible wearable for continuous heart monitoring in patients with atrial fibrillation.

An analysis suggests 1-in-5 high-risk patients will experience at least one cardiovascular complication within the first year following non-cardiac surgery.

An analysis of data from more than 9 million women details the increased odds of developing gestational diabetes, gestational hypertension, and other complications associated with having polycystic ovary syndrome.

A trial presented at TCT 2020 suggests crushed prasugrel provided no reperfusion benefit when compared against integral tablet in STEMI patients.

An analysis of the Partners YOUNG-MI registry details the increased risk of mortality for facing women after myocardial infarction versus men.

An analysis of data from the REGARDS study suggests more than half of all patients hospitalized with heart failure were prescribed 10 or more medications at discharge.

A study presented at UEG Week 2020 suggests a minimally-invasive, outpatient procedure combined with GLP-1 RA therapy could help diabetics eliminate the need for insulin therapy.

An analysis of Explorys data presented at UEG Week 2020 suggests bariatric surgery in obese diabetics could reduce risk of pancreatic cancer.

Muthiah Vaduganathan, MD, MPH, of Brigham and Women's discusses the barriers to preventing optimal prescribing practices for SGLT2 inhibitor and GLP-1 receptor agonist therapies.

A meta-analysis published in JAMA Cardiology details reductions in cardiovascular and kidney outcomes associated with SGLT2 inhibitor use in diabetes patients.

A meta-analysis published in JAMA Cardiology details reductions in cardiovascular and kidney outcomes associated with SGLT2 inhibitor use in diabetes patients.

This episode of the Endocrine Outlook podcast features a discussion around the cardiorenal benefits of SGLT2 inhibitors and GLP-1 receptor agonists.

A Penn Medicine study found addition of prompts to an EHR did not significantly change the percentage of patients prescribed a statin.

Results of a recent analysis that found ablation was associated with lower risk of dementia compared to medical therapy alone suggest rhythm control could help preserve overall health.

An analysis of data from DiRECT suggests diabetes remission was linked to restoration of pancreas size and function.

An analysis of the Look AHEAD Study suggests improved blood sugar control was linked to improved executive function and neurologic health among patients with type 2 diabetes.

A cardiologist from Brigham and Women's Hospital discusses prescribing SGLT2 inhibitors to patients already receiving or with an indication for diuretics or RAAS inhibitors.